Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant aspirin in colorectal cancer with PI3K pathway mutations
2015-004240-19Phase 3Active
- Sponsor
- Karolinska Institutet
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing Aspirin (Trombyl) arm with Placebo arm (2 arms). Primary endpoint: Time to Recurrence (TTR). Started Dec 2015; status: active.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2015-004240-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004240-19.